| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/ADD.12679 |
| P698 | PubMed publication ID | 25040898 |
| P2093 | author name string | Peter Hauser | |
| Eric Dieperink | |||
| Paul Thuras | |||
| Carl Isenhart | |||
| Christine Pocha | |||
| Kelly McMaken | |||
| Bret Fuller | |||
| Rebecca Lenox | |||
| P2860 | cites work | Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial | Q29396936 |
| Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups | Q29614459 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options | Q29620126 | ||
| Sofosbuvir for previously untreated chronic hepatitis C infection | Q29620137 | ||
| Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry | Q30909447 | ||
| The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse | Q31933682 | ||
| The efficacy of motivational interviewing: A meta-analysis of controlled clinical trials | Q35546370 | ||
| The impact of lifetime alcohol use on hepatitis C treatment outcomes in privately insured members of an integrated health care plan | Q36185899 | ||
| Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes. | Q36619642 | ||
| The epidemiology of hepatitis C infection in the United States | Q36892181 | ||
| Management of chronic hepatitis C in veterans: the potential of integrated care models | Q37194817 | ||
| Barriers to HCV treatment in the era of triple therapy: a prospective multi-centred study in clinical practice | Q42230180 | ||
| Hepatitis C virus infection in patients with clinically diagnosed alcoholic liver diseases | Q42979374 | ||
| Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study | Q42984741 | ||
| Exploratory study of oral combination antiviral therapy for hepatitis C. | Q42987725 | ||
| Role of alcohol in the progression of liver disease caused by hepatitis C virus infection | Q42988450 | ||
| Management of hepatitis C patients by primary care physicians in the USA: results of a national survey | Q43034294 | ||
| Psychiatric disorders among veterans with hepatitis C infection | Q44081498 | ||
| The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. | Q44979610 | ||
| Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness. | Q45354911 | ||
| Alcohol use and treatment of hepatitis C virus: results of a national multicenter study | Q45416751 | ||
| Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C. | Q45731609 | ||
| Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis | Q45756849 | ||
| Assessing competence in the use of motivational interviewing | Q48497252 | ||
| A multi-disciplinary approach to treating hepatitis C with interferon and ribavirin in alcohol-dependent patients with ongoing abuse. | Q50555720 | ||
| Treatment rates in patients with chronic hepatitis C after liver biopsy. | Q50575063 | ||
| Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. | Q53118691 | ||
| Effects of brief counselling among male heavy drinkers identified on general hospital wards. | Q54026507 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | alcohol consumption | Q2647488 |
| chronic hepatitis C | Q55779873 | ||
| P304 | page(s) | 1869-1877 | |
| P577 | publication date | 2014-08-14 | |
| P1433 | published in | Addiction | Q4681106 |
| P1476 | title | Efficacy of motivational enhancement therapy on alcohol use disorders in patients with chronic hepatitis C: a randomized controlled trial | |
| P478 | volume | 109 |
| Q91713726 | A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection |
| Q40389298 | Adapting a computer-delivered brief alcohol intervention for veterans with Hepatitis C. |
| Q28070280 | Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections |
| Q38863461 | Behavioral Interventions to Reduce Alcohol Use Among Patients with Hepatitis C: A Systematic Review |
| Q91954715 | Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases |
| Q36306966 | Differential effects and temporal course of attentional and motivational training on excessive drinking. |
| Q36722832 | Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review |
| Q64960668 | Integrating Care for Patients With Chronic Liver Disease and Mental Health and Substance Use Disorders. |
| Q40101753 | Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland--using spontaneous resolvers as the benchmark comparator |
| Q59356988 | The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial |
| Q46535653 | Treating substance use disorders in patients with hepatitis C. |
| Q26781897 | Update on Alcohol and Viral Hepatitis |
Search more.